Ocata Therapeutics Inc (NASDAQ:OCAT)

6.73
Delayed Data
As of May 22
 +0.11 / +1.66%
Today’s Change
4.95
Today|||52-Week Range
12.73
+10.51%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Ocata Therapeutics Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +137.74% increase from the last price of 6.73.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Ocata Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$53.0K
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -7.69%
 
 
 
 
 
 
Growthannually 0.00%
 
 
 
 
 

Sales

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually 10,651.58%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account